Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial

Borgers, J S W ; Burgers, F H ; Terveer, E M ; van Leerdam, M E ; Korse, C M ; Kessels, R ; Flohil, C C ; Blank, C U ; Schumacher, T N ; van Dijk, M ; Henderickx, J G E ; Keller, J J ; Verspaget, H W ; Kuijper, E J ; Haanen, J B A G

BMC cancer, 2022-12, Vol.22 (1), p.1366-11, Article 1366 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível